Cargando…
Tumor vasculature is a key determinant for the efficiency of nanoparticle-mediated siRNA delivery
Delivering small interfering RNA (siRNA) to tumors using clinically viable formulations remains the primary technical hurdle that prevents the development of siRNA therapy for cancer treatment. Over the past several years, significant effort has been devoted to explore novel delivery strategies, whe...
Autores principales: | Li, L, Wang, R, Wilcox, D, Zhao, X, Song, J, Lin, X, Kohlbrenner, W M, Fesik, S W, Shen, Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389750/ https://www.ncbi.nlm.nih.gov/pubmed/21956688 http://dx.doi.org/10.1038/gt.2011.146 |
Ejemplares similares
-
Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling
por: Sahay, Gaurav, et al.
Publicado: (2013) -
siRNA-mediated off-target gene silencing triggered by a 7 nt complementation
por: Lin, Xiaoyu, et al.
Publicado: (2005) -
Nanoparticle-Mediated Systemic Delivery of siRNA for Treatment of Cancers and Viral Infections
por: Draz, Mohamed Shehata, et al.
Publicado: (2014) -
Amphiphilic Peptides for Efficient siRNA Delivery
por: Mozaffari, Saghar, et al.
Publicado: (2019) -
Advances in Lipid Nanoparticles for siRNA Delivery
por: Tam, Yuen Yi C., et al.
Publicado: (2013)